Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Drug sales to reach $1.9 trillion within 5 years?
Mullard, Asher.
Nat Rev Drug Discov ; 22(3): 172, 2023 03.
Article in English | MEDLINE | ID: covidwho-2273171
2.
GSK buys Affinivax for up to $3.3 billion, bolstering its vaccine pipeline.
Mullard, Asher.
Nat Rev Drug Discov ; 21(7): 480-481, 2022 07.
Article in English | MEDLINE | ID: covidwho-1937411

Subject(s)
Vaccines , Humans , Vaccines/therapeutic use
3.
What should go into a booster shot for COVID-19?
Mullard, Asher.
Nat Rev Drug Discov ; 21(8): 548, 2022 08.
Article in English | MEDLINE | ID: covidwho-1921579

Subject(s)
COVID-19 , Humans , Vaccination
4.
From pandemic preparedness to public-private partnerships.
Mullard, Asher.
Nat Rev Drug Discov ; 21(7): 486-487, 2022 07.
Article in English | MEDLINE | ID: covidwho-1921578

Subject(s)
Pandemics , Public-Private Sector Partnerships , Humans
5.
R&D budgets boom, but success rates falter.
Mullard, Asher.
Nat Rev Drug Discov ; 21(4): 249, 2022 04.
Article in English | MEDLINE | ID: covidwho-1860313

Subject(s)
Budgets , Humans , United States
6.
Pfizer's small-molecule antiviral misses on COVID prevention.
Mullard, Asher.
Nat Rev Drug Discov ; 21(6): 406, 2022 06.
Article in English | MEDLINE | ID: covidwho-1830005

Subject(s)
Antiviral Agents , COVID-19 , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , COVID-19/prevention & control , Drug Industry , Humans
7.
The quest to prevent MS - and understand other post-viral diseases.
Mullard, Asher.
Nature ; 603(7903): 784-786, 2022 03.
Article in English | MEDLINE | ID: covidwho-1773942

Subject(s)
Virus Diseases , Humans , Virology , Virus Diseases/prevention & control
8.
COVID-19 platform trial delivers
Mullard, Asher.
[Unspecified Source]; 2020.
Non-conventional in English | [Unspecified Source] | ID: grc-750427
9.
Pfizer's COVID-19 vaccine secures first full FDA approval.
Mullard, Asher.
Nat Rev Drug Discov ; 20(10): 728, 2021 10.
Article in English | MEDLINE | ID: covidwho-1397841
10.
COVID-19 vaccine success enables a bolder vision for mRNA cancer vaccines, says BioNTech CEO.
Mullard, Asher.
Nat Rev Drug Discov ; 20(7): 500-501, 2021 07.
Article in English | MEDLINE | ID: covidwho-1275885
11.
Long COVID's long R&D agenda.
Mullard, Asher.
Nat Rev Drug Discov ; 20(5): 329-331, 2021 05.
Article in English | MEDLINE | ID: covidwho-1195603

Subject(s)
COVID-19/complications , COVID-19/therapy , Clinical Trials as Topic , Drug Development , Hospitalization , Humans , Research , Post-Acute COVID-19 Syndrome
12.
RECOVERY 1 year on: a rare success in the COVID-19 clinical trial landscape.
Mullard, Asher.
Nat Rev Drug Discov ; 20(5): 336-337, 2021 05.
Article in English | MEDLINE | ID: covidwho-1189190

Subject(s)
Antiviral Agents , COVID-19 Drug Treatment , Clinical Trials as Topic , Antiviral Agents/classification , Antiviral Agents/pharmacology , COVID-19/epidemiology , Clinical Protocols , Clinical Trials as Topic/methods , Clinical Trials as Topic/organization & administration , Clinical Trials as Topic/standards , Communicable Diseases, Emerging/therapy , Humans , Research Design/standards , SARS-CoV-2 , Treatment Outcome , United Kingdom
13.
FDA authorizes first single-shot COVID-19 vaccine.
Mullard, Asher.
Nat Rev Drug Discov ; 20(4): 251, 2021 04.
Article in English | MEDLINE | ID: covidwho-1132042

Subject(s)
COVID-19 Vaccines , COVID-19/prevention & control , Drug Approval/statistics & numerical data , COVID-19/epidemiology , COVID-19 Vaccines/classification , COVID-19 Vaccines/pharmacology , Humans , SARS-CoV-2/immunology , United States , United States Food and Drug Administration , Vaccine Potency
14.
Kathy High.
Mullard, Asher.
Nat Rev Drug Discov ; 20(3): 170-171, 2021 03.
Article in English | MEDLINE | ID: covidwho-1132041

Subject(s)
Hemophilia A/genetics , Genetic Therapy/methods , Humans
15.
COVID-19 platform trial delivers.
Mullard, Asher.
Nat Rev Drug Discov ; 19(8): 501, 2020 08.
Article in English | MEDLINE | ID: covidwho-1059211
16.
Emer Cooke.
Mullard, Asher.
Nat Rev Drug Discov ; 20(1): 12-13, 2021 01.
Article in English | MEDLINE | ID: covidwho-1012661

Subject(s)
COVID-19 Vaccines/therapeutic use , COVID-19/prevention & control , Decision Making , Drug Development , SARS-CoV-2/isolation & purification , Technology Assessment, Biomedical/standards , COVID-19/transmission , COVID-19/virology , Drug Approval , Humans , Patient Care Planning
17.
COVID-19 vaccines buoy hope.
Mullard, Asher.
Nat Rev Drug Discov ; 20(1): 8, 2021 01.
Article in English | MEDLINE | ID: covidwho-960302
18.
How COVID vaccines are being divvied up around the world.
Mullard, Asher.
Nature ; 2020 Nov 30.
Article in English | MEDLINE | ID: covidwho-951840
19.
Tillman Gerngross.
Mullard, Asher.
Nat Rev Drug Discov ; 19(9): 580-581, 2020 09.
Article in English | MEDLINE | ID: covidwho-829024

Subject(s)
Antibodies/immunology , COVID-19 , Coronavirus Infections/immunology , Drug Industry/methods , Humans , Pandemics , Pneumonia, Viral/immunology
20.
Lidia Fonseca.
Mullard, Asher.
Nat Rev Drug Discov ; 19(7): 438-439, 2020 07.
Article in English | MEDLINE | ID: covidwho-740030

Subject(s)
Coronavirus Infections/epidemiology , Drug Development/methods , Drug Discovery/methods , Drug Industry/organization & administration , Pneumonia, Viral/epidemiology , COVID-19 , Humans , Pandemics , Technology/methods
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL